# Insmed, Inc. (INSM)

Insmed presents at major healthcare conferences, highlighting progress for patients. The company's stock shows resilience amid mixed trial data, supported by recent revenue reports and product launch updates.

### About Insmed, Inc.
Insmed, Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare diseases.  
Insmed, Inc. uses the ticker $INSM for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- Insmed, Inc. (INSM) trading volume is up 25.28% from the previous week.
- Insmed, Inc. (INSM) social dominance is up 505.56% from the previous week.
- Insmed, Inc. (INSM) engagements is up 11.17% from the previous week.
- Insmed, Inc. (INSM) posts created is up 92.86% from the previous week.

### Price: $148.80
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$insm/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$insm/time-series/close.tsv)  
The stock price is showing resilience with a 7-day increase, supported by positive mentions of analyst upgrades and inclusion in the MSCI World Index, despite mixed trial data for brensocatib. Recent strong revenue reports and product launch updates are likely contributing to this upward momentum.  

24-Hour: 1.77%
7-Day: -0.15%
30-Day: -7.85%

1-Year High: $211.40 on 2025-12-01  
1-Year Low: $64.80 on 2025-04-10  
  
  
### AltRank: [-----]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$insm/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$insm/time-series/alt_rank.tsv)  
Insmed, Inc. (INSM) is currently AltRank #1,145 based on combined combined social and market metrics
Daily Average: [---]  
[--] Week: [-----] +135  
[--] Month: [-----] +468  
[--] Months: [-----] +1,094  
[--] Year: [-----] +622  
1-Year High: [-----] on 2025-03-03  
1-Year Low: [--] on 2025-07-06  
  
  
### Galaxy Score: [-----]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$insm/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$insm/time-series/galaxy_score.tsv)  
Current Value: [-----]  
Daily Average: [--]  
[--] Week: [--] [---]  
[--] Month: [--] [---]  
[--] Months: [--] [---]  
[--] Year: [--] [---]  
1-Year High: [--] on 2025-05-15  
1-Year Low: [--] on 2025-09-15  
  
  
### Engagements: [-----] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$insm/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$insm/time-series/interactions.tsv)  
Current Value: [-----]  
Daily Average: [------]  
[--] Week: [------] +11%  
[--] Month: [-------] -64%  
[--] Months: [---------] +90%  
[--] Year: [----------] +56%  
1-Year High: [-------] on 2025-10-24  
1-Year Low: [---] on 2025-04-12  

Engagements by network (24h):
TikTok: [--]
News: [--]
YouTube: [--]
Reddit: [--]
X: [-----]

  
  
### Mentions: [--] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$insm/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$insm/time-series/posts_active.tsv)  
Current Value: [--]  
Daily Average: [---]  
[--] Week: [---] -1.80%  
[--] Month: [---] -23%  
[--] Months: [-----] -57%  
[--] Year: [------] +129%  
1-Year High: [-----] on 2025-07-07  
1-Year Low: [--] on 2025-09-15  

Mentions by network (24h):
TikTok: [--]
News: [--]
YouTube: [--]
Reddit: [--]
X: [--]

  
  
### Creators: [--] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$insm/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$insm/time-series/contributors_active.tsv)  
[--] unique social accounts have posts mentioning Insmed, Inc. (INSM) in the last [--] hours which is up 1.90% from [--] in the previous [--] hours
Daily Average: [---]  
[--] Week: [---] -4.40%  
[--] Month: [---] -29%  
[--] Months: [-----] -66%  
[--] Year: [-----] +292%  
1-Year High: [-----] on 2025-07-07  
1-Year Low: [--] on 2025-04-13  

The most influential creators that mention Insmed, Inc. in the last [--] hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@Biotech2k1](/creator/twitter/Biotech2k1)           | [--]    | [------]    | [--]     | [---]         |
| [@BuyTheUgly](/creator/twitter/BuyTheUgly)           | [--]    | [--]        | [--]     | [---]         |
| [@Speculator_io](/creator/twitter/Speculator_io)     | [--]    | [-------]   | [--]     | [---]         |
| [@smartestrading](/creator/twitter/smartestrading)   | [--]    | [-----]     | [--]     | [---]         |
| [@doepke_michel](/creator/twitter/doepke_michel)     | [--]    | [------]    | [--]     | [--]          |
| [@mariostario2019](/creator/twitter/mariostario2019) | [--]    | [--]        | [--]     | [--]          |
| [@SheliaL53055245](/creator/twitter/SheliaL53055245) | [--]    | [---]       | [--]     | [--]          |
| [@semodough](/creator/twitter/semodough)             | [--]    | [------]    | [--]     | [--]          |
| [@grok](/creator/twitter/grok)                       | [--]    | [---------] | [--]     | [--]           |
| [@TJOpp63](/creator/twitter/TJOpp63)                 | [--]   | [---]       | [--]     | [--]           |

[View More](/list/creators/$insm/100)
  
  
### Sentiment: 87%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$insm/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$insm/time-series/sentiment.tsv)  
Current Value: 87%  
Daily Average: 84%  
[--] Week: 75% -25%  
[--] Month: 83% +5%  
[--] Months: 83% -10%  
[--] Year: 83% +9%  
1-Year High: 100% on 2025-04-17  
1-Year Low: 32% on 2025-03-15  

Most Supportive Themes:
- Analyst Upgrades and Price Targets: (30%) Analysts are increasing their price targets and upgrading Insmed's stock, signaling confidence in its future performance.
- Positive Trial Data and Drug Development: (25%) Recent positive trial results for Insmed's key drugs, TPIP and brensocatib, are boosting investor confidence and driving positive sentiment.
- Inclusion in Top Employer Lists: (15%) Recognition on 'Science' magazine's top employers list highlights Insmed's strong company culture and industry standing.
  
Most Critical Themes:
- Valuation Concerns: (60%) Some analysts express concerns that Insmed's current valuation may be overinflated, despite positive underlying fundamentals.
- Market Dominance and Competition: (40%) While a significant player, Insmed's market share is relatively small, and the biotechnology sector faces intense competition.
  
  
  
### Social Dominance: 0.00607%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$insm/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$insm/time-series/social_dominance.tsv)  
Current Value: 0.00607%  
Daily Average: 0.022%  
[--] Week: 0.011% +0.0091%  
[--] Month: 0.008% -0.016%  
[--] Months: 0.008% -0.021%  
[--] Year: 0.008% -0.015%  
1-Year High: 0.194% on 2025-07-07  
1-Year Low: 0.0049% on 2025-09-15  
  
  
### Market Dominance: 0.036%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$insm/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$insm/time-series/market_dominance.tsv)  
Current Value: 0.036%  
Daily Average: 0%  
1-Year High: 0.52% on 2025-03-31  
1-Year Low: 0.017% on 2025-05-13  
  
  
### Market Cap: $31,724,428,514
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$insm/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$insm/time-series/market_cap.tsv)  
Current Value: $31,724,428,514  
Daily Average: $25,777,290,305  
[--] Week: $31,724,428,514 -0.15%  
[--] Month: $31,724,428,514 -6.60%  
[--] Months: $31,724,428,514 +18%  
[--] Year: $31,724,428,514 +121%  
1-Year High: $45,088,144,081 on 2025-12-01  
1-Year Low: $11,783,754,848 on 2025-04-10  

### Top Insmed, Inc. Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"Some implied moves for earnings next week - [---] companies reporting(2of2): $OLED 8.7% $COCO 11.7% $SEDG 15.6% $MDT 4.9% $BKNG 7.1% $CAR 10.0% $SO 3.3% $ETSY 11.9% $INSM 9.9% $MDGL 8.9% $TZOO 14.9% $FLR 10.1% $TOL 6.0% $MKSI 9.3% $FVRR 11.7% $BLCO 7.5% $PODD 9.0% $WING 13.1% $GPN 9.2% $OXY 4.5% $NTR 4.9% $CAKE 7.2% $CF 4.7% $HLF 14.6% $TAP 6.4% $BHC 5.0% https://www.optionmillionaires.com/some-implied-moves-for-earnings-next-wee-feb-17th-feb-20th-375-companies-reporting/ https://www.optionmillionaires.com/some-implied-moves-for-earnings-next-wee-feb-17th-feb-20th-375-companies-reporting/"  
[X Link](https://x.com/OMillionaires/status/2022684416829440125) [@OMillionaires](/creator/x/OMillionaires) 2026-02-14T14:48Z 143.2K followers, [----] engagements


"Were sharing the latest on our progress for patients at the TD Cowen 46th Annual Healthcare Conference and the @LeerinkPartners Global Healthcare Conference. Learn more: https://investor.insmed.com/2026-02-13-Insmed-To-Present-at-March-2026-Investor-Conferences https://investor.insmed.com/2026-02-13-Insmed-To-Present-at-March-2026-Investor-Conferences"  
[X Link](https://x.com/Insmed/status/2022280716852093003) [@Insmed](/creator/x/Insmed) 2026-02-13T12:04Z [----] followers, [---] engagements


"Comm'l-stage bio trading w/in 1.10X of their lows since 10/1/25 $VSTM LGSOC (ovarian) combo did $17.5MM in Q425 sales ($1MM beat) Should $OCUL have taken $16/sh last Sept $TLX $800MM FY25 sales $INSM $RYTM $ANIP $LGND $ALVO $CRSP $XERS $XNCR $SRPT $ACAD $ARGX $GMAB $XBI $IBB"  
[X Link](https://x.com/NightOwlBiotech/status/2022100929957498894) [@NightOwlBiotech](/creator/x/NightOwlBiotech) 2026-02-13T00:10Z [----] followers, [----] engagements


"One thing I debated is increasing position limits in my top conviction stocks. They are the companies who have multiple successful late stage and commercial programs. If biotech ever had another crash I could see $INSM at 15% and $BBIO at 10%. $AXSM still has to show some of its drugs can be better as Sunosi and Symbravo are a bust. https://twitter.com/i/web/status/2020165291779428482 https://twitter.com/i/web/status/2020165291779428482"  
[X Link](https://x.com/Biotech2k1/status/2020165291779428482) [@Biotech2k1](/creator/x/Biotech2k1) 2026-02-07T15:58Z 34.2K followers, [----] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing